ETF DAILY NEWS

Wedbush Estimates Inozyme Pharma’s Q2 Earnings (NASDAQ:INZY)

Inozyme Pharma, Inc. (NASDAQ:INZY – Free Report) – Analysts at Wedbush dropped their Q2 2025 earnings per share (EPS) estimates for Inozyme Pharma in a report issued on Wednesday, May 14th. Wedbush analyst D. Nierengarten now expects that the company will post earnings per share of ($0.34) for the quarter, down from their previous forecast […]

May 18, 2025 - 06:58
 0
Wedbush Estimates Inozyme Pharma’s Q2 Earnings (NASDAQ:INZY)
Inozyme Pharma, Inc. (NASDAQ:INZY – Free Report) – Analysts at Wedbush dropped their Q2 2025 earnings per share (EPS) estimates for Inozyme Pharma in a report issued on Wednesday, May 14th. Wedbush analyst D. Nierengarten now expects that the company will post earnings per share of ($0.34) for the quarter, down from their previous forecast […]
Read More

Tags:

Previous Article

Q2 EPS Estimate for Market Vectors Indian Rupee/USD ETN Boosted by Analyst

Next Article

Intellicheck Q2 EPS Forecast Decreased by Northland Capmk

Related Posts

Schonfeld Strategic Advisors LLC Invests $263,000 in FB Bancorp, Inc. (NASDAQ:FBLA)

Schonfeld Strategic Advisors LLC Invests $263,000 in FB...

May 13, 2025  0

Similarweb (SMWB) Expected to Announce Earnings on Tuesday

Similarweb (SMWB) Expected to Announce Earnings on Tuesday

May 12, 2025  0

Flutter Entertainment (NYSE:FLUT) & Oblong (NYSE:OBLG) Head-To-Head Survey

Flutter Entertainment (NYSE:FLUT) & Oblong (NYSE:OBLG) ...

May 19, 2025  0